Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,310
Closed -$1.76M 517
2025
Q4
$1.76M Buy
7,310
+1,535
+27% +$393K 0.01% 286
2025
Q3
$1.58M Hold
5,775
0.01% 286
2025
Q2
$1.49M Buy
5,775
+756
+15% +$180K 0.01% 303
2025
Q1
$1.12M Buy
+5,019
New +$1.17M 0.01% 319
2024
Q3
Sell
-2,928
Closed -$560K 461
2024
Q2
$560K Buy
+2,928
New +$594K 0.01% 304
2024
Q1
Sell
-5,320
Closed -$915K 457
2023
Q4
$915K Sell
5,320
-17,553
-77% -$2.7M 0.01% 303
2023
Q3
$3.38M Sell
22,873
-1,994
-8% -$361K 0.05% 199
2023
Q2
$5.43M Sell
24,867
-7
-0% -$1.56K 0.07% 150
2023
Q1
$5.45M Buy
24,874
+18
+0.1% +$3.9K 0.08% 121
2022
Q4
$5.17M Sell
24,856
-27,913
-53% -$6.13M 0.08% 128
2022
Q3
$11.5M Sell
52,769
-3,420
-6% -$778K 0.15% 77
2022
Q2
$11.8M Hold
56,189
0.16% 78
2022
Q1
$13.6M Buy
56,189
+10,300
+22% +$2.49M 0.15% 91
2021
Q4
$12M Sell
45,889
-612
-1% -$159K 0.06% 95
2021
Q3
$12.3M Sell
46,501
-1,620
-3% -$443K 0.07% 84
2021
Q2
$11.9M Sell
48,121
-3,330
-6% -$700K 0.07% 81
2021
Q1
$9.98M Buy
51,451
+7,684
+18% +$1.54M 0.07% 89
2020
Q4
$9.3M Buy
43,767
+19,968
+84% +$3.98M 0.07% 92
2020
Q3
$4.08M Buy
23,799
+2,050
+9% +$379K 0.05% 124
2020
Q2
$4.18M Sell
21,749
-1,920
-8% -$314K 0.05% 112
2020
Q1
$3.49M Buy
23,669
+236
+1% +$37.6K 0.04% 171
2019
Q4
$3.63M Sell
23,433
-4,284
-15% -$617K 0.03% 156
2019
Q3
$3.75M Buy
27,717
+1,194
+5% +$156K 0.04% 150
2019
Q2
$3.24M Buy
+26,523
New +$2.94M 0.03% 173

Other funds holding RMD

Banco Santander's RMD Position: Q1 2026 in Review

Banco Santander sold out of ResMed (RMD) in Q1 2026, closing a stake of 7,310 shares — an estimated $1.76M sold.

Banco Santander first reported a position in RMD in Q2 2019 and held it in 24 quarters. The position peaked at $13.6M in Q1 2022. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Banco Santander reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Banco Santander sold 7,310 ResMed shares in Q1 2026, an estimated $1.76M.
  • Banco Santander first reported a position in ResMed in Q2 2019 and held it in 24 quarters.
  • Banco Santander's ResMed position peaked at $13.6M in Q1 2022.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Banco Santander's 13F filing for Q1 2026, filed 8 May 2026.